Summary: Parkinson’s disease affects more than 10 million people globally, standing second only to dementia among devastating neurological disorders. The disease is pathologically characterized by the progressive destruction of dopamine-producing neurons, leading to tremors, severe motor dysfunction, rigidity, and cognitive decline. For decades, neuroscientists studying the condition have relied on animal models engineered through artificial gene splicing or the injection of highly toxic chemicals. While useful, these older methods do not fully replicate the natural, spontaneous way Parkinson’s takes root in the human population.
In a new study, researchers successfully developed the first non-toxic animal model of Parkinson’s disease using a naturally occurring mouse pathogen called Theiler’s murine encephalomyelitis virus (TMEV).
The pilot study proves that a simple, transient viral infection can trigger the exact long-term brain damage, dopamine depletion, and physical walking disabilities observed in human Parkinson’s patients. The breakthrough provides structural proof for the long-held scientific theory that everyday viruses can serve as the hidden environmental fuse for late-life neurodegenerative diseases.
Key Facts
- The Non-Toxic Pivot: Traditional models require artificial toxin exposures that fail to capture the complex, natural origins of neurodegeneration. The TMEV model introduces a completely non-toxic, viral-driven pathway to mimic human disease onset.
- Targeted Dopaminergic Destruction: Within seven days of exposure, the virus successfully infected dopamine-producing brain cells. By month one, these vital neurons were entirely destroyed, a loss validated through specialized dopamine-mimicking pharmacological tests.
- Chronic Motor Deficits: Using the standardized “pole test” to measure physical speed and motor coordination, infected models were significantly slower than controls, a physical impairment that remained locked in at week 20 when the study concluded.
- Gait & Balance Abnormalities: Utilizing a specialized, high-resolution treadmill evaluating over 100 distinct walking factors, researchers verified that the viral infection caused systemic weakness and progressive gait degradation identical to clinical human Parkinson’s presentation.
- The Hit-and-Run Theory: The study strongly reinforces the “hit-and-run” viral theory of neurodegeneration, the concept that a common virus contracted in youth or mid-life can induce a slow-burning inflammatory cascade that destroys brain networks decades later.
- Translational Horizons: Backed by this validated baseline, the Texas A&M team is scaling up operations to test the TMEV framework directly against chemical models, searching for early blood biomarkers, and mapping out the specific immune-cell signaling loops that turn a common infection into a fatal brain condition.
Source: Texas A&M
Scientists usually use animal models when studying Parkinson’s disease because these models mimic the disease well. They are limited, however, because they require either gene modifications or the injection of toxicants, which may not accurately represent how the disease occurs in humans.
But now, researchers at Texas A&M University have developed a model that uses a nontoxic way to generate the symptoms of Parkinson’s: infection with a virus called Theiler’s murine encephalomyelitis virus (TMEV), a natural pathogen in mice.
Their study is a game changer because it proves that a simple viral infection can trigger the exact brain damage and physical disabilities in animal models that are seen in people with Parkinson’s disease — and it sets the stage for additional studies.
“The toxic-exposure models are useful for studying Parkinson’s, but not all people who are exposed to chemicals go on to develop Parkinson’s, so these models cannot show all the ways a disease as complex as Parkinson’s actually begins or develops over time in people,” said Candice Brinkmeyer-Langford, a neurogenerative disease expert with the Texas A&M University School of Public Health at Texas A&M Health.
Parkinson’s affects more than 10 million people worldwide, making it second only to dementia among brain disorders. It destroys the cells that produce dopamine, a chemical essential for smooth body movement, leading to problems with balance and walking, tremors in the hands or fingers and overall stiffness, as well as mental or emotional distress.
Its origins are unknown, but for decades, experts have believed that the disease could be triggered by the brain inflammation caused by viruses—even those contracted decades earlier — as well as by a combination of a person’s genetics and environmental factors. This idea recently was affirmed by Brinkmeyer-Langford and others at Texas A&M in the case of another devastating motor neuron disease, amyotrophic lateral sclerosis (ALS).
“Viruses are known to cause entirely different diseases based on a person’s genetics,” she said. “For example, the Epstein-Barr virus causes mononucleosis, but may also contribute to cancer or multiple sclerosis, and SARS-CoV-2 can attack the heart and brain as well as the lungs.”
For this pilot study to test the validity of TMEV in studying Parkinson’s, the researchers conducted experiments to measure the following:
- Brain cell infection and damage. One week after infection, the researchers confirmed that the virus had infected the dopamine-producing brain cells. At one month after infection, the dopamine-producing cells were destroyed in the site of viral infection. Dopamine-induced behaviors were compared between 13 infected animal models and 14 healthy control animal models after administering a dopamine-mimicking drug which produced a distinct movement pattern confirming dopamine neuron loss. This test confirmed that the virus caused a significant loss of these crucial dopamine brain cells over time.
- Speed and coordination. They compared 13 infected animal models against 14 healthy control animal models to track and measure their motor skills with a standard assessment called the pole test to determine if losing dopamine-producing cells causes the physical movement problems typically seen in Parkinson’s patients. Animal models infected with TMEV had slower times to complete the test compared to the healthy control models, and this still was the case at week 20, when the study ended.
- Gait abnormalities. They used a specialized treadmill, which evaluated over 100 factors involved in walking, motor function and balance, to analyze how quickly and efficiently the animal models walked. The test confirmed that the virus caused physical weakness following the loss of dopamine producing cells due to viral infection, proving that the virus damaged the brain in a similar way as seen in Parkinson’s patients.
Now that this innovative model has been proven, Brinkmeyer-Langford said future studies will include testing the TMEV model directly against standard, older animal models used in Parkinson’s research, looking for early warning signs and biological markers for Parkinson’s and analyzing how the body’s immune response to a virus changes the brain.
“The clock is ticking, since the rapidly aging global population means the number of people with Parkinson’s is expected to jump significantly,” she said.
Others involved with the study — all from Texas A&M — were graduate student Tae Wook Kang with the College of Veterinary Medicine and Biomedical Sciences (VMBS), Rahul Srinivasan with the Naresh K. Vashisht College of Medicine, and C. Jane Welsh with VMBS and the Department of Neuroscience and Experimental Therapeutics. They also are associated with the Texas A&M Institute for Neuroscience.
Funding: The study was published in Brain, Behavior, and Immunity-Health and was supported by the National Institute for Neurological Disorders and Stroke and a Texas A&M College of Veterinary Medicine and Biomedical Sciences Graduate Trainee Grant.
Key Questions Answered:
A: Imagine trying to understand how a house fire starts naturally, but your only research method is intentionally blowing up the kitchen with dynamite. That is what using toxic chemical models in labs is like, it forces Parkinson’s symptoms to appear instantly, but it skips the natural, slow-burning steps of how the actual human disease develops over decades. By using a natural, non-toxic mouse virus (TMEV), the Texas A&M team can watch the disease unfold step-by-step from a simple infection. It allows scientists to see the true biological origin story of Parkinson’s for the very first time.
A: This revolves around the “hit-and-run” theory of neurodegeneration. A virus can enter the brain, do its immediate damage, and be completely cleared out by your immune system, leaving no trace behind. However, that brief infection can act as a genetic tripwire, triggering a chronic, low-grade inflammatory firestorm in your brain’s immune cells. Over decades, this background inflammation slowly chokes out and destroys your delicate, dopamine-producing neurons. The body can mask this cellular loss for a long time, but once enough dopamine cells die off, the physical tremors, stiffness, and walking issues of Parkinson’s suddenly break through.
A: No, absolutely not. Dr. Candice Brinkmeyer-Langford explains that viruses are highly selective saboteurs, they cause completely different diseases depending on a person’s unique genetic code. For example, the Epstein-Barr virus gives one teenager mononucleosis, but in another person, it can silently spark multiple sclerosis or cancer decades later. Developing Parkinson’s requires a perfect storm: you need a specific genetic vulnerability combined with a specific environmental trigger, like a viral infection or pesticide exposure. This new model will help researchers figure out exactly which genetic profiles turn a routine viral illness into a neurodegenerative disease.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neurology and Parkinson’s disease research news
Author: Ann Kellett
Source: Texas A&M
Contact: Ann Kellett – Texas A&M
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Theiler’s murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson’s disease” by Tae Wook Kang, Rahul Srinivasan, Candice Brinkmeyer-Langford, C. Jane Welsh. Brain, Behavior & Immunity – Health
DOI:10.1016/j.bbih.2026.101230
Abstract
Theiler’s murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with a prevalence of over ten million patients worldwide. The etiology of PD remains unclear but neuroinflammation specifically associated with viral infection has risen as a possible contributor to the disease.
Classical animal models of PD reproduce certain pathophysiological outcomes such as the degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc), but these models are limited by the need to inject harmful neurotoxins to induce disease-like symptoms.
We present a virally induced neuroinflammatory model of PD in C57BL/6J mice using a naturally occurring pathogen, Theiler’s murine encephalomyelitis virus (TMEV), as the infectious agent. This model offers a tool for advancing our understanding of PD pathogenesis and potential treatment options.
